Glucocorticoids [Standard Dose] — Competitive Intelligence Brief

Glucocorticoids [Standard Dose] (Glucocorticoids [Standard Dose]) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Glucocorticoid. Area: Immunology.

phase 3 Glucocorticoid Glucocorticoid receptor (GR) Immunology Small molecule

Target snapshot

Glucocorticoids [Standard Dose] (Glucocorticoids [Standard Dose]) — University of Pennsylvania. Glucocorticoids suppress immune and inflammatory responses by binding to glucocorticoid receptors and inhibiting pro-inflammatory cytokine production.

Comparator set (6 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Glucocorticoids [Standard Dose] TARGET	Glucocorticoids [Standard Dose]	University of Pennsylvania	phase 3	Glucocorticoid	Glucocorticoid receptor (GR)
Medrol	methylprednisolone	Generic (originally Upjohn/Pfizer)	marketed	Glucocorticoid (corticosteroid)	Annexin A1, Short transient receptor potential channel 5, Glucocorticoid receptor	1957-10-01
Prelone	prednisolone	Generic (originally Schering)	marketed	Glucocorticoid (corticosteroid)	Annexin A1, Corticosteroid-binding globulin, G-protein coupled bile acid receptor 1	1955-01-01
Glucocorticoid (GC)	Glucocorticoid (GC)	First Affiliated Hospital of Zhejiang University	marketed	Glucocorticoid	Glucocorticoid receptor (GR)
Dexamethasone low dose	Dexamethasone low dose	Manuel Taboada Muñiz	marketed	Glucocorticoid (corticosteroid)	Glucocorticoid receptor (GR)
Methylprednisolone (MP)	Methylprednisolone (MP)	Masonic Cancer Center, University of Minnesota	marketed	Glucocorticoid (corticosteroid)	Glucocorticoid receptor (GR)
Intravenous Dexamethasone	Intravenous Dexamethasone	University of British Columbia	marketed	Glucocorticoid (corticosteroid)	Glucocorticoid receptor (GR)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Glucocorticoid class)

1. Research in Real-Life Ltd · 2 drugs in this class
2. NICHD Neonatal Research Network · 2 drugs in this class
3. UMC Utrecht · 2 drugs in this class
4. University of Pennsylvania · 2 drugs in this class
5. First Affiliated Hospital of Zhejiang University · 1 drug in this class
6. GlaxoSmithKline · 1 drug in this class
7. ClinAmygate · 1 drug in this class
8. Instituto de Investigación Sanitaria y Biomédica de Alicante · 1 drug in this class
9. First Affiliated Hospital of Wenzhou Medical University · 1 drug in this class
10. Guangzhou JOYO Pharma Co., Ltd · 1 drug in this class